These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 10090139

  • 1. TSH-secreting pituitary macroadenoma: rapid tumor shrinkage and recovery from hyperthyroidism with octreotide.
    Fischler MP, Reinhart WH.
    J Endocrinol Invest; 1999 Jan; 22(1):64-5. PubMed ID: 10090139
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature.
    Yoenem A, Cakyr B, Azal O, Corakcy A, Kutlu M, Oezata M.
    Endocr Regul; 1999 Dec; 33(4):169-74. PubMed ID: 10700085
    [Abstract] [Full Text] [Related]

  • 4. Successful pregnancy in an infertile woman with a thyrotropin-secreting macroadenoma treated with somatostatin analog (octreotide).
    Caron P, Gerbeau C, Pradayrol L, Simonetta C, Bayard F.
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1164-8. PubMed ID: 8772594
    [Abstract] [Full Text] [Related]

  • 5. [Effect of long-term treatment with octreotide-lar in a TSH-secreting pituitary macroadenoma and secondary hyperthyroidism].
    Del Monte P, Bernasconi D, Ruelle A, Marugo A, Marugo M, Torre R.
    Minerva Endocrinol; 2005 Jun; 30(2):95-9. PubMed ID: 15988405
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898
    [Abstract] [Full Text] [Related]

  • 7. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
    Iglesias P, Díez JJ.
    J Endocrinol Invest; 1998 Dec; 21(11):775-8. PubMed ID: 9972679
    [Abstract] [Full Text] [Related]

  • 8. Preoperative long-acting octreotide treatment for invasive thyrotropin-secreting pituitary macroadenoma after previous radioiodine thyroid ablation.
    Gruszka A, Zielinski GM, Kunert-Radek J.
    J Clin Neurosci; 2014 Feb; 21(2):340-2. PubMed ID: 23958483
    [Abstract] [Full Text] [Related]

  • 9. A thyrotropin-secreting pituitary adenoma as a cause of thyrotoxic periodic paralysis.
    Alings AM, Fliers E, de Herder WW, Hofland LJ, Sluiter HE, Links TP, van der Hoeven JH, Wiersinga WM.
    J Endocrinol Invest; 1998 Nov; 21(10):703-6. PubMed ID: 9854688
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [New elements in the diagnosis and treatment of thyrotropic pituitary adenomas with hyperthyroidism].
    Linquette M, Cappoen JP, Mazzuca M.
    Bull Acad Natl Med; 1989 Feb; 173(2):217-20; discussion 221-2. PubMed ID: 2765997
    [Abstract] [Full Text] [Related]

  • 12. [Octreotide in the treatment of thyrotropin-secreting pituitary adenomas].
    Podoba J, Hnilica P, Makaiová I, Kovácová S, Rybár M, Gecík K, Belan V, Steno J.
    Vnitr Lek; 1997 Sep; 43(9):607-10. PubMed ID: 9750471
    [Abstract] [Full Text] [Related]

  • 13. The treatment of a thyrotropin-secreting pituitary macroadenoma with octreotide in twin pregnancy.
    Blackhurst G, Strachan MW, Collie D, Gregor A, Statham PF, Seckl JE.
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):401-4. PubMed ID: 12201834
    [Abstract] [Full Text] [Related]

  • 14. Different responses to chronic somatostatin analogues in patients with central hyperthyroidism.
    Mannavola D, Persani L, Vannucchi G, Zanardelli M, Fugazzola L, Verga U, Facchetti M, Beck-Peccoz P.
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):176-81. PubMed ID: 15670193
    [Abstract] [Full Text] [Related]

  • 15. Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma.
    Fukuhara N, Horiguchi K, Nishioka H, Suzuki H, Takeshita A, Takeuchi Y, Inoshita N, Yamada S.
    Endocr J; 2015 Feb; 62(1):21-7. PubMed ID: 25273395
    [Abstract] [Full Text] [Related]

  • 16. Macro- and microadenoma of thyrotropin secreting pituitary tumors--two clinical cases.
    Hubalewska-Hola A, Fröss K, Kostecka-Matyja M, Sowa-Staszczak A, Szybiński Z, Huszno B, Ptak M.
    Przegl Lek; 2003 Feb; 60(11):768-71. PubMed ID: 15058054
    [Abstract] [Full Text] [Related]

  • 17. [Hypophyseal thyrotropin adenomas at Yaounde (Cameroon). Analysis of two case reports: improvement with somatostatin analogue (SMS 201-995)].
    Nouedoui C, Moukouri E, Juimo AG, Dongmo L, Zok FD, Tapko JB, Muna WF.
    Tunis Med; 1999 Mar; 77(3):154-8. PubMed ID: 10392035
    [No Abstract] [Full Text] [Related]

  • 18. Asymptomatic thyrotropin-secreting pituitary macroadenoma in a 13-year-old girl: successful first-line treatment with somatostatin analogs.
    Rabbiosi S, Peroni E, Tronconi GM, Chiumello G, Losa M, Weber G.
    Thyroid; 2012 Oct; 22(10):1076-9. PubMed ID: 22947349
    [Abstract] [Full Text] [Related]

  • 19. Thyrotropin secreting pituitary adenoma effectively treated with octreotide.
    Fukuda T, Yokoyama N, Tamai M, Imaizumi M, Kimura H, Tominaga T, Ashizawa K, Kiriyama T, Yoshimine H, Ohishi K, Eguchi K.
    Intern Med; 1998 Dec; 37(12):1027-30. PubMed ID: 9932634
    [Abstract] [Full Text] [Related]

  • 20. [111In-DTPA-D-Phe]-octreotide scintigraphy in functioning and non-functioning pituitary adenomas.
    Boni G, Ferdeghini M, Bellina CR, Matteucci F, Castro Lopez E, Parenti G, Canapicchi R, Bianchi R.
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):90-3. PubMed ID: 9002759
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.